Navigation Links
Dr. Kim-Chi Vu in Portland Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler
Date:7/24/2009

PORTLAND, Ore., July 24 /PRNewswire/ -- Kim-Chi Vu, M.D., P.C. has selected Artefill, the first and only FDA-approved microsphere-enhanced collagen filler for the correction of smile lines. Dr. Vu has been an avid Artefill user the past several years due to its proven success and effectiveness for the long lasting correction of wrinkles.

Dr. Vu commented, "Artefill is a great product for many reasons. First and foremost it has wonderful results that keep our patients satisfied. It has also shown to last longer in comparison to other injectable fillers which is a lot more cost efficient."

This simple, in-office procedure takes approximately fifteen minutes to complete. A patient is injected with Artefill similar to other dermal fillers with the key difference being its lasting effect. The unique microspheres in Artefill are not absorbed by the body and therefore provide the support the skin needs for long lasting natural feeling results. This is different from temporary dermal fillers that are made of different kinds of natural or synthetic materials that are completely absorbed by the body over time and require repeat injections to maintain wrinkle correction. A skin test is required prior to treatment or approximately four (4) weeks ahead of time, to ensure a patient is not allergic to the collagen or anesthetic in Artefill.

Artefill is only offered by a select group of physicians in Oregon and is not available at all physician offices. Dr. Vu is one of the company trained and select few company sponsored physicians who has the skills and experience needed to administer the product.

Mrs. A. Vark, a patient of Dr. Vu's said, "Over the past two years I have been injected with Juvederm, Restylane and other fillers but the results were very temporary. I decided to use Artefill as it was proven to have a long lasting effect and I can honestly say that the results actually improve over time. It's amazing and I have already recommended it to my friends."

About Artefill:

Artefill is the first and only FDA-approved microsphere-enhanced collagen filler for the correction of nasolabial folds, better known as smile lines. The safety and effectiveness of Artefill has been extensively studied over the past eight years. Since Artefill was approved in 2006, over 10 thousand patients have been treated successfully with very high satisfaction rates.

Suneva Medical, Inc., a medical technology company focused on developing, manufacturing and commercializing novel, differentiated aesthetic products for the dermatology, plastic and cosmetic surgery markets, markets and manufactures Artefill. The Company was formed in April 2009 to deliver the same great product that physicians and patients have embraced over the past several years. For more information visit www.artefill.com or www.sunevamedical.com.

About Dr. Kim-Chi Vu:

One of only a handful of female plastic surgeons in Portland, Dr. Kim-Chi Vu attended the University of Portland as an undergraduate and graduated from medical school at the Oregon Health Sciences University, where she also completed her surgical residency. Dr. Vu certified by the American Board of Plastic Surgery, specializes in not only cosmetic and reconstructions, but also in hand trauma surgeries. During her residency, Dr. Vu was involved in several research projects, including the heparin effect on thrombocytopenia, bioresorbable ribs stabilization in rib fractures, and a clinical study on composite grafting for correction of bilateral cleft nasal deformity. For more information visit http://www.drvuplastics.com/home.htm.

ATTENTION MEDIA: To download Artefill patient before and after pictures visit http://www.artefill.com/content/c/beforeandafter/overview.asp.

    Contact:
    Clare Campos
    503-297-8555
    clare.campos@drvuplastics.com


'/>"/>
SOURCE Dr. Kim-Chi Vu
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Contents of the McGinnis Mansion Refurbishes Portland, Oregon Sexual Minority Youth Center
2. West Coast Bank Will Sponsor the Heart of Doernbecher Auction at the Portland Art Museum, October 20, 2007
3. Portland Physician Wins AMA Distinguished Service Award
4. Providence St. Vincent bringing IMRISneuro, the worlds most advanced surgical MRI to Portland, Oregon
5. The Oregon Clinic Extends Patient Care Services Across Metro Portland with Time Warner Telecoms Metro Ethernet Service
6. Oregon Cosmetic Vein Center Opens in Portland, Among First on West Coast to Offer Brand New, FDA-Approved Procedures and Technologies
7. Northwest Run/Walk for Epilepsy - Portland
8. Linking Up the Cold Chain is Focus of The JoC Conferences First Cool Cargoes Conference, May 12-13, in Portland, Oregon
9. tw telecom Extends Portland Area Network Into Tualatin and Lake Oswego Business Districts
10. Bishops Barbershop - Keeping Portland a Great Place to Live
11. Hundreds March on Seattle, Portland and Spokane
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... 28, 2017 , ... Ushio America proudly introduces the new ... energy-saving solution for F32T8 fluorescent lamps on most instant-start and programmed-start electronic ballasts ... rated lamps utilize the existing electronic ballast, saving labor and maintenance costs. It’s ...
(Date:4/28/2017)... ... April 28, 2017 , ... From April 30 to ... Care Medicine will host industry leaders for the annual spring Convention & Expo, ... the industry adapt to the issues currently affecting urgent care and on-demand healthcare. ...
(Date:4/28/2017)... ... 28, 2017 , ... Researchers at Moffitt Cancer Center ... CentrePoint Data Hub in a sample of participants enrolled in an ongoing cancer ... monitoring solutions for the global scientific community. The company’s new CentrePoint Data Hub ...
(Date:4/28/2017)... ... , ... Rob Lowe is a popular actor that has been in many ... educational purpose as the host of the “Informed” series. The program focuses on many ... the series focuses on thyroid cancer. , Although thyroid cancer is an uncommon type ...
(Date:4/27/2017)... Jacksonville, Florida (PRWEB) , ... April 27, 2017 , ... ... qualified candidates. But they will rapidly reject an outdated healthcare executive resume. , “If ... good look at your executive resume and wondering if it’s as ready as you ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017 Eyevensys, a ... first non-viral gene expression technology that enables the safe, ... to address a wide range of ophthalmic diseases, announces ... Healthcare products Regulatory Agency (MHRA) to advance its technology ... ...
(Date:4/19/2017)... , April 19, 2017 Cardiology devices segment is ... period The Cardiology Devices segment is likely to ... 15 Mn in 2018 over 2017. By the end of ... valuation close to US$ 700 Mn, expanding at a CAGR ... dominated the Asia Pacific reprocessed medical ...
(Date:4/19/2017)... 19, 2017 Global Prostate Cancer Therapeutics ... the prostate cancer therapeutics market analyzes the current ... prevalence of prostate cancer, launch of promising emerging ... of new drugs & therapeutic biological products, and ... to lesser side effects are some of the ...
Breaking Medicine Technology: